Search research articles
Contact Us
Filters
Showing results (81-90 of 114) with videos related to
Page
of 12
Sort By:
Annals of Internal Medicine
|
July 1, 1971
Chloral hydrate and warfarin therapy
J Koch-Weser, E M Sellers, J A Udall, et al.
Seminars in Hematology
|
April 1, 1993
Continuous infusion of porcine factor VIII for the treatment of patients with factor VIII inhibitors
R D Bona, M Riberio, A U Klatsky, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 1, 1986
Production and characterization of a monoclonal antibody (A1-3) that binds selectively to activated monocytes and inhibits monocyte procoagulant activity
V A Ewan, W Cieplinski, W W Hancock, et al.
The Journal of Laboratory and Clinical Medicine
|
May 1, 1982
Mononuclear cell modulation of fibroblast procoagulant activity
J H Korn, F R Rickles, V A Ewan, et al.
FEBS Letters
|
February 24, 1992
The first epidermal growth factor domain of human coagulation factor VII is essential for binding with tissue factor
B J Clarke, F A Ofosu, S Sridhara, et al.
Transplantation
|
April 1, 1985
Immunohistological analysis of serial biopsies taken during human renal allograft rejection. Changing profile of infiltrating cells and activation of the coagulation system
W W Hancock, D Gee, P De Moerloose, et al.
Contemporary Clinical Trials
|
July 23, 2011
Competing events in patients with malignant disease who are at risk for recurrent venous thromboembolism
S Parpia, J A Julian, L Thabane, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
August 1, 1992
Prognostic significance of blood coagulation tests in carcinoma of the lung and colon
M Z Wojtukiewicz, L R Zacharski, T E Moritz, et al.
Gastroenterology
|
February 1, 1987
Activation of blood coagulation in Crohn's disease. Increased plasma fibrinopeptide A levels and enhanced generation of monocyte tissue factor activity
R L Edwards, J B Levine, R Green, et al.
Thrombosis and Haemostasis
|
February 1, 1994
The use of intermediate and high purity factor VIII products in the treatment of von Willebrand disease
W T Hanna, R D Bona, C E Zimmerman, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 114) with videos related to
Sort By:
Page
of 12
Annals of Internal Medicine
|
July 1, 1971
Chloral hydrate and warfarin therapy
J Koch-Weser, E M Sellers, J A Udall, et al.
Seminars in Hematology
|
April 1, 1993
Continuous infusion of porcine factor VIII for the treatment of patients with factor VIII inhibitors
R D Bona, M Riberio, A U Klatsky, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 1, 1986
Production and characterization of a monoclonal antibody (A1-3) that binds selectively to activated monocytes and inhibits monocyte procoagulant activity
V A Ewan, W Cieplinski, W W Hancock, et al.
The Journal of Laboratory and Clinical Medicine
|
May 1, 1982
Mononuclear cell modulation of fibroblast procoagulant activity
J H Korn, F R Rickles, V A Ewan, et al.
FEBS Letters
|
February 24, 1992
The first epidermal growth factor domain of human coagulation factor VII is essential for binding with tissue factor
B J Clarke, F A Ofosu, S Sridhara, et al.
Transplantation
|
April 1, 1985
Immunohistological analysis of serial biopsies taken during human renal allograft rejection. Changing profile of infiltrating cells and activation of the coagulation system
W W Hancock, D Gee, P De Moerloose, et al.
Contemporary Clinical Trials
|
July 23, 2011
Competing events in patients with malignant disease who are at risk for recurrent venous thromboembolism
S Parpia, J A Julian, L Thabane, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
August 1, 1992
Prognostic significance of blood coagulation tests in carcinoma of the lung and colon
M Z Wojtukiewicz, L R Zacharski, T E Moritz, et al.
Gastroenterology
|
February 1, 1987
Activation of blood coagulation in Crohn's disease. Increased plasma fibrinopeptide A levels and enhanced generation of monocyte tissue factor activity
R L Edwards, J B Levine, R Green, et al.
Thrombosis and Haemostasis
|
February 1, 1994
The use of intermediate and high purity factor VIII products in the treatment of von Willebrand disease
W T Hanna, R D Bona, C E Zimmerman, et al.
Page
of 12